COMP <GO>
PACS vs THC // EV/EBITDA & P/E VALUATION
PACS Group Inc. (NYSE) VS. Tenet Healthcare Corporation (NYSE) • 15-METRIC TALLY: PACS 4
— THC 8
▲ EV/EBITDA & P/E VALUATION LEADER: THC
LAST: $47.81 (-3.76%) • MKT CAP: $7.87B
valuation
15.5x
LAST: $273.25 (+0.99%) • MKT CAP: $21.79B
valuation
6.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PACS VS. THC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PACS | THC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 24.60% | 27.60% | -3.00 | THC | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 15.5x | 6.3x | +9.20 | THC | /valuation <GO> |
| Free Cash Flow Yield | 2.11% | 11.61% | -9.50 | THC | /fcf-yield <GO> |
| Operating Margin | 5.90% | 16.50% | -10.60 | THC | /operating-margins <GO> |
| Net Profit Margin | 3.60% | 11.10% | -7.50 | THC | /net-margins <GO> |
| Revenue Growth (YoY) | 29.40% | 3.10% | +26.30 | PACS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.24 | 2.08 | +0.16 | PACS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 6/9 | +3.00 | PACS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.4 | 54.8 | +8.60 | PACS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 0.97 | -0.02 | THC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.5x | 8.6x | +25.90 | THC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.87B | $21.79B | -$13.92B | THC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PACS REV | THC REV | PACS GROSS % | THC GROSS % | PACS FCF | THC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.29B | $21.31B | — | — | $166.3M | $2.53B |
| FY 2024 | $4.09B | $20.68B | — | — | $183.4M | $1.12B |
| FY 2023 | $3.11B | $20.56B | — | — | -$76.3M | $1.45B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PACS // BETA 0.95
THC // BETA 0.97